Table 1.
Inclusion Criteria | Exclusion Criteria |
---|---|
Clinical studies reporting outcomes of arthroscopic BMS for nonprimary talar OCLs | Data not interpretable |
Levels I-IV clinical studies | Combination of patient/treatment groups and/or no separate data per group |
Five or more patients included | Follow-up period <6 months |
Peer-reviewed studies | Patient overlap in different studies |
Full-text available studies published in the English language | Treatment option inappropriately described |
Asymptomatic lesions | |
Level V evidence | |
Animal studies/cadaveric studies |
BMS = bone marrow stimulation; OCL = osteochondral lesion.